Medical Marijuana Inc (OTCMKTS:MJNA) has recently appointed Tyler Whatcott as Chief Technology Officer. He will manage and develop web platforms and Information Technology to cope up with the development of Medical Marijuana’s existing business. Whatcott is also responsible for the expansion of Medical Marijuana’s business across the world.
Whatcott will lead technological operations
Commenting on the appointment of CTO, Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, said Whatcott would play a vital role in leading the company’s technological operations. He welcomed the perspective of Whatcott on how technology will shape the offerings of Medical Marijuana and support its innovation in the cannabis industry.
To his credit, Whatcott managed and led technology-related projects both on a global and national level for over ten years. In his previous stint, Whatcott held the position of Senior Director (IT Applications) at many large companies. Whatcott would improve the return on investment by focusing on redesigned and new brand websites of Medical Marijuana. He will help enhance customers’ experience on its websites in the purchase of cannabis products.
Whatcott on his appointment
Whatcott said Medical Marijuana is a leader in the cannabis industry for over ten years, and he is eager to be part of the skilled and hardworking team to support global wellness. He promises to use his previous experience to optimize consumer-facing entities of Medical Marijuana and make the navigation easier for customers as they interact with its brands and products.
Cannabis sales would touch $22 billion
According to Brightfield Group estimates, the sales of cannabis worldwide are expected to reach $22 billion by the year 2022. The search rates for CBD are expected to grow by 117% in 2019.
Nutritious compounds and CBD in hemp oil supplements are minerals, vitamins, flavonoids, and terpenes. Whatcott streamlines the websites of Medical Marijuana to help consumers choose high-quality CBD products from the comfort of home. The company produces CBD oil with the help of the CO2 extraction process, which offers stability and safety when compared to other extraction processes. The CO2 extraction method is non-flammable and non-toxic. It allows extracting the compounds without any side effects to the consumers.
Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) Introduces Pure Sunfarm Products In Manitoba As Its Terminates Facility Agreements
Post Views: 100 Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) has announced that its cannabis production joint venture Pure Sunfarms has started...
Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada
Post Views: 194 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...
AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) Unveils its NeuCovix™ Test That Can Accurately Classify COVID-19 Neutralization Tests
Post Views: 63 AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) has completed a study focusing on the performance of its NeuCovix™ rapid test...
Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets
Post Views: 188 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...
1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada
Post Views: 165 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...
Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe
Post Views: 138 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...